Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr (Q43077326)
Jump to navigation
Jump to search
scientific article published in May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr |
scientific article published in May 2010 |
Statements
1 reference
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr (English)
1 reference
Mihai Gheorghiade
1 reference
Christopher M O'Connor
1 reference
Marco Metra
1 reference
Ileana Piña
1 reference
Marvin A Konstam
1 reference
Paul J Hauptman
1 reference
Patricia Wedge
1 reference
Alan B Miller
1 reference
John E A Blair
1 reference
Maria C Bahit
1 reference
Peter Carson
1 reference
Markus Haass
1 reference
Ron M Oren
1 reference
Richard Patten
1 reference
Sherryn Roth
1 reference
Jonathan D Sackner-Bernstein
1 reference
Brian Traver
1 reference
Thomas Cook
1 reference
Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators
1 reference
1 May 2010
1 reference
1 reference
Identifiers
1 reference